Purine synthesis promotes maintenance of brain tumor initiating cells in glioma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Neuroscience

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nn.4537PMID 28346452PMCID PMC6015494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamine metabolism in cancer therapy

  2018cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Metabolic Heterogeneity in Human Lung Tumors.

  2016cited by this paper
• From Krebs to clinic: glutamine metabolism to cancer therapy

  2016cited by this paper
• mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle

  2016cited by this paper
• Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells.

  2016cited by this paper
• From Krebs to clinic: glutamine metabolism to cancer therapy

  2016cited by this paper
• Mitochondrial Control by DRP1 in Brain Tumor Initiating Cells

  2015cited by this paper
• Regulation of mammalian nucleotide metabolism and biosynthesis

  2015cited by this paper
• MYC, Metabolism, and Cancer.

  2015cited by this paper
• Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance

  2015cited by this paper
• The Zinc Finger Transcription Factor ZFX Is Required for Maintaining the Tumorigenic Potential of Glioblastoma Stem Cells

  2014cited by this paper
• Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK

  2014cited by this paper
• Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.

  2014cited by this paper
• Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

  2013cited by this paper
• Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake

  2013cited by this paper
• Neural stem cells: generating and regenerating the brain.

  2013cited by this paper
• Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• Current clinical development of PI3K pathway inhibitors in glioblastoma.

  2012cited by this paper
• IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

  2012cited by this paper
• Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

  2012cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

  2012cited by this paper
• The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming

  2011cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• Acidic stress promotes a glioma stem cell phenotype

  2011cited by this paper
• Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

  2009cited by this paper
• SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

  2009cited by this paper
• Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research

  2009cited by this paper
• The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• The molecular determinants of de novo nucleotide biosynthesis in cancer cells.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis*

  2009cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells

  2008cited by this paper
• P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition

  2008cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Systemic lupus erythematosus

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

  2006cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Systemic lupus erythematosus

  2001cited by this paper
• Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.

  2000cited by this paper
• Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha Interferon

  2000cited by this paper
• Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.

  1996cited by this paper
• Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.

  1996cited by this paper
• Physiological functions of the pentose phosphate pathway

  1986cited by this paper
• Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis.

  1985cited by this paper
• Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide

  1972cited by this paper

• Systemic hypoxia suppresses solid tumor growth

  2026cites this paper
• IMP metabolic mechanisms and IMPDH targeting strategies in tumor metabolic reprogramming and therapy (Review)

  2026cites this paper
• Marek's disease virus hijacks host nucleotide metabolism via UL23-mediated c-Myc activation.

  2026cites this paper
• From Healthy Scans to Annotated Tumors: A Tumor Fabrication Framework for 3D Brain Mri Synthesis

  2025cites this paper
• Adaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients

  2025cites this paper
• Radiation-induced Glioblastoma Stem Cell-mediated T Cell Exhaustion via EGR1-Gal3-LAG3 Axis in Glioblastoma.

  2025cites this paper
• Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement

  2025cites this paper
• Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissues

  2025cites this paper
• Selective regulation and cellular metabolism by the lactate transporter MCT4 in GBM

  2025cites this paper
• Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth

  2025cites this paper
• Temozolomide-Derived AIC Is Incorporated into Purine Synthesis in Glioblastoma

  2025cites this paper
• Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells.

  2025cites this paper
• Integrative Multi-Omics Analysis Identifies Nuclear Factor I as a Key Driver of Dysregulated Purine Metabolism in DIPG

  2025cites this paper
• Y12C mutation disrupts IMPDH cytoophidia and alters cancer metabolism

  2025cites this paper
• Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition

  2025cites this paper
• PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway

  2025cites this paper
• Notch1 and Major Vault Proteins Modulate Temozolomide Resistance in Glioblastoma

  2025cites this paper
• Lnc‐TPT1‐AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression

  2025cites this paper
• Therapeutic targeting de novo purine biosynthesis driven by β-catenin-dependent PPAT upregulation in hepatoblastoma

  2025cites this paper
• Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance

  2025cites this paper
• Metabolic pathways of Alternative Lengthening of Telomeres in pan-carcinoma

  2025cites this paper
• NUP98‐p65 complex regulates DNA repair to maintain glioblastoma stem cells

  2025cites this paper
• Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer.

  2025cites this paper
• Investigating the relevance of nucleotide metabolism in the prognosis of glioblastoma through bioinformatics models

  2025cites this paper
• Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosis

  2025cites this paper
• TP53-dependent antitumor effects of DHODH Inhibition in nasopharyngeal carcinoma

  2025cites this paper
• Phosphocreatine promotes epigenetic reprogramming to facilitate glioblastoma growth through stabilizing BRD2.

  2024cites this paper
• The de novo purine synthesis enzyme Adssl1 promotes cardiomyocyte proliferation and cardiac regeneration.

  2024cites this paper
• One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma

  2024cites this paper
• Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough.

  2024cites this paper
• Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

  2024cites this paper
• De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases

  2024cites this paper
• A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice

  2024cites this paper
• Vitamin B6 Pathway Maintains Glioblastoma Cell Survival in 3D Spheroid Cultures

  2024cites this paper
• Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment

  2024cites this paper
• Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva

  2024cites this paper
• Preliminary Analysis of Solute Carrier Family in Nucleotide Rescue Synthesis in Glioma

  2024cites this paper
• Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients

  2024cites this paper
• Thiophenyl Derivatives of Nicotinamide Are Metabolized by the NAD Salvage Pathway into Unnatural NAD Derivatives That Inhibit IMPDH and Are Toxic to Peripheral Nerve Cancers.

  2024cites this paper
• De novo and salvage purine synthesis pathways across tissues and tumors.

  2024cites this paper
• Purinosomes involved in the regulation of tumor metabolism: current progress and potential application targets

  2024cites this paper
• Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells

  2024influential citation
• G6PD maintains the VSMC synthetic phenotype and accelerates vascular neointimal hyperplasia by inhibiting the VDAC1–Bax-mediated mitochondrial apoptosis pathway

  2024cites this paper
• Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming

  2024cites this paper
• Reactivating PTEN to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly

  2024cites this paper
• ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM.

  2024cites this paper
• The hidden architects of glioblastoma multiforme: Glioma stem cells

  2024cites this paper
• Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy

  2023cites this paper
• Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance

  2023cites this paper
• Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS)

  2023cites this paper
• Cochlear metabolomics, highlighting novel insights of purine metabolic alterations in age-related hearing loss.

  2023cites this paper
• GTP signaling links metabolism, DNA repair, and responses to genotoxic stress.

  2023cites this paper
• PAICS ubiquitination recruits UBAP2 to trigger phase separation for purinosome assembly.

  2023cites this paper
• Metabolic remodeling in astrocytes: Paving the path to brain tumor development.

  2023cites this paper
• ДИАГНОСТИКА ГЛИОБЛАСТОМЫ НА ОСНОВЕ ИЗМЕРЕНИЯ АКТИВНОСТИ НЕКОТОРЫХ ФЕРМЕНТОВ // DIAGNOSIS OF GLIOBLASTOMA BASED ON THE MEASUREMENT OF ACTIVITY OF SOME ENZYMES

  2023cites this paper
• Cancer stem cells in brain tumors: From origin to clinical implications

  2023cites this paper
• Metabolomic differentiation of tumor core versus edge in glioma.

  2023cites this paper
• Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment

  2023cites this paper
• Glioblastoma Metabolism: Insights and Therapeutic Strategies

  2023cites this paper
• Lysine catabolism reprograms tumour immunity through histone crotonylation

  2023cites this paper
• GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity

  2023cites this paper
• Emerging roles of nucleotide metabolism in cancer.

  2023cites this paper
• GTP signaling links metabolism, DNA repair, and responses to genotoxic stress

  2023cites this paper
• Regulation of nucleotide metabolism in cancers and immune disorders.

  2023cites this paper
• SREBP2 maintains glioblastoma stem cells through keeping the balance between cholesterol biosynthesis and uptake.

  2023cites this paper
• An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1

  2023cites this paper
• The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme

  2023cites this paper
• Xanthine dehydrogenase rewires metabolism and the survival of nutrient deprived lung adenocarcinoma cells by facilitating UPR and autophagic degradation

  2023cites this paper
• Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models.

  2023cites this paper
• Glutamine Metabolism in Cancer Stem Cells: A Complex Liaison in the Tumor Microenvironment

  2023cites this paper
• FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis.

  2023cites this paper
• Cutting the umbilical cord: Cancer stem cell-targeted therapeutics.

  2022cites this paper
• Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage

  2022cites this paper
• Immunotoxicity responses to polystyrene nanoplastics and their related mechanisms in the liver of zebrafish (Danio rerio) larvae.

  2022cites this paper
• Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways

  2022cites this paper
• Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway

  2022cites this paper
• Therapeutic targeting of differentiation state-dependent metabolic vulnerabilities in DIPG

  2022cites this paper
• Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas

  2022cites this paper
• Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells

  2022cites this paper
• Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer

  2022cites this paper
• Metabolism in the progression and metastasis of brain tumors

  2022cites this paper
• Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies

  2022cites this paper
• Metabolomic Profiles of Human Glioma Inform Patient Survival

  2022influential citation
• Contribution of Model Organisms to Investigating the Far-Reaching Consequences of PRPP Metabolism on Human Health and Well-Being

  2022cites this paper
• Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas

  2022cites this paper
• β2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages.

  2022cites this paper
• Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma

  2022cites this paper
• HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny

  2022cites this paper
• Effect of Expression of Nuclear-Encoded Cytochrome C Oxidase Subunit 4 Isoforms on Metabolic Profiles of Glioma Cells

  2022cites this paper
• ATIC-Associated De Novo Purine Synthesis Is Critically Involved in Proliferative Arterial Disease

  2022cites this paper
• NRF2-directed PRPS1 upregulation to promote the progression and metastasis of melanoma

  2022cites this paper
• Factors affecting the radiation response in glioblastoma

  2022cites this paper
• PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability

  2022cites this paper
• Repurposing Clemastine to Target Glioblastoma Cell Stemness

  2022cites this paper
• Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas

  2022cites this paper
• Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma.

  2022cites this paper
• Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.

  2022cites this paper
• Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma

  2021cites this paper
• ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3

  2021cites this paper
• Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy

  2021cites this paper